Wedoany.com Report on Mar 11th, Medical technology company BD and Envetec Sustainable Technologies have recently completed a pilot project for a polystyrene recycling feasibility study. The project, implemented in the United States and Europe, utilizes Envetec's GENERATIONS technology to convert regulated medical waste, such as unused BD BBL prepared plates and culture plates, into recyclable polymer flakes. This process includes shredding, separation, and low-energy chemical disinfection, ultimately extruding the material into polystyrene pellets and molding them into new culture plate prototypes.

Envetec's GENERATIONS technology has been deployed in biopharmaceutical, life sciences facilities, hospitals, and the food and beverage industry to process regulated medical and biohazardous waste, converting it into clean polymer flakes suitable for recycling. Envetec CEO Malcolm Bell stated: "This pilot project is the first step in a broader effort to demonstrate the feasibility of recovering and recycling multiple plastic products within the medical supply chain. By creating a proof of concept for the safe handling of regulated plastics and their return to productive use, we are opening the door to sustainable solutions that help the industry avoid landfill and keep valuable materials in circulation."

Nikos Pavlidis, Global President of BD Diagnostic Solutions, added: "Single-use devices made from high-quality plastics play a critical role in modern healthcare due to their safety, ease of use, and scalability, but we recognize the long-term environmental impact these materials can have. This pilot project, conducted by the BD Institute for Sustainable Medical Technology, is an important step towards achieving circular economy solutions for other high-volume medical consumables made from common plastics, such as blood collection tubes, syringes, and packaging." Both companies see clear opportunities to scale up the pilot to reduce reliance on virgin plastics and keep high-value polymers in circulation.